Probiotics beyond the farm: Benefits, costs, and considerations of using antibiotic alternatives in livestock

Kyle R. Leistikow, Rachelle E. Beattie, K. Hristova
{"title":"Probiotics beyond the farm: Benefits, costs, and considerations of using antibiotic alternatives in livestock","authors":"Kyle R. Leistikow, Rachelle E. Beattie, K. Hristova","doi":"10.3389/frabi.2022.1003912","DOIUrl":null,"url":null,"abstract":"The increasing global expansion of antimicrobial resistant infections warrants the development of effective antibiotic alternative therapies, particularly for use in livestock production, an agricultural sector that is perceived to disproportionately contribute to the antimicrobial resistance (AMR) crisis by consuming nearly two-thirds of the global antibiotic supply. Probiotics and probiotic derived compounds are promising alternative therapies, and their successful use in disease prevention, treatment, and animal performance commands attention. However, insufficient or outdated probiotic screening techniques may unintentionally contribute to this crisis, and few longitudinal studies have been conducted to determine what role probiotics play in AMR dissemination in animal hosts and the surrounding environment. In this review, we briefly summarize the current literature regarding the efficacy, feasibility, and limitations of probiotics, including an evaluation of their impact on the animal microbiome and resistome and their potential to influence AMR in the environment. Probiotic application for livestock is often touted as an ideal alternative therapy that might reduce the need for antibiotic use in agriculture and the negative downstream impacts. However, as detailed in this review, limited research has been conducted linking probiotic usage with reductions in AMR in agricultural or natural environments. Additionally, we discuss the methods, including limitations, of current probiotic screening techniques across the globe, highlighting approaches aimed at reducing antibiotic usage and ensuring safe and effective probiotic mediated health outcomes. Based on this information, we propose economic and logistical considerations for bringing probiotic therapies to market including regulatory roadblocks, future innovations, and the significant gaps in knowledge requiring additional research to ensure probiotics are suitable long-term options for livestock producers as an antibiotic alternative therapy.","PeriodicalId":73065,"journal":{"name":"Frontiers in antibiotics","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in antibiotics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frabi.2022.1003912","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

The increasing global expansion of antimicrobial resistant infections warrants the development of effective antibiotic alternative therapies, particularly for use in livestock production, an agricultural sector that is perceived to disproportionately contribute to the antimicrobial resistance (AMR) crisis by consuming nearly two-thirds of the global antibiotic supply. Probiotics and probiotic derived compounds are promising alternative therapies, and their successful use in disease prevention, treatment, and animal performance commands attention. However, insufficient or outdated probiotic screening techniques may unintentionally contribute to this crisis, and few longitudinal studies have been conducted to determine what role probiotics play in AMR dissemination in animal hosts and the surrounding environment. In this review, we briefly summarize the current literature regarding the efficacy, feasibility, and limitations of probiotics, including an evaluation of their impact on the animal microbiome and resistome and their potential to influence AMR in the environment. Probiotic application for livestock is often touted as an ideal alternative therapy that might reduce the need for antibiotic use in agriculture and the negative downstream impacts. However, as detailed in this review, limited research has been conducted linking probiotic usage with reductions in AMR in agricultural or natural environments. Additionally, we discuss the methods, including limitations, of current probiotic screening techniques across the globe, highlighting approaches aimed at reducing antibiotic usage and ensuring safe and effective probiotic mediated health outcomes. Based on this information, we propose economic and logistical considerations for bringing probiotic therapies to market including regulatory roadblocks, future innovations, and the significant gaps in knowledge requiring additional research to ensure probiotics are suitable long-term options for livestock producers as an antibiotic alternative therapy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
农场以外的益生菌:在牲畜中使用抗生素替代品的效益、成本和考虑
抗微生物耐药性感染在全球范围内的日益扩大,需要开发有效的抗生素替代疗法,特别是用于畜牧生产。畜牧生产是一个农业部门,消耗了全球近三分之二的抗生素供应,被认为对抗微生物耐药性危机的贡献过大。益生菌和益生菌衍生的化合物是有前景的替代疗法,它们在疾病预防、治疗和动物表现方面的成功应用值得关注。然而,益生菌筛查技术不足或过时可能无意中导致了这场危机,而且很少进行纵向研究来确定益生菌在动物宿主和周围环境中AMR传播中的作用。在这篇综述中,我们简要总结了当前关于益生菌的功效、可行性和局限性的文献,包括对其对动物微生物组和耐药性的影响及其影响环境中AMR的潜力的评估。益生菌在牲畜中的应用通常被吹捧为一种理想的替代疗法,可以减少农业中抗生素的使用需求和负面的下游影响。然而,如本综述所述,在农业或自然环境中,将益生菌的使用与AMR的减少联系起来的研究有限。此外,我们还讨论了目前全球益生菌筛查技术的方法,包括局限性,强调了旨在减少抗生素使用和确保安全有效的益生菌介导的健康结果的方法。基于这些信息,我们提出了将益生菌疗法推向市场的经济和后勤考虑因素,包括监管障碍、未来的创新以及需要额外研究的重大知识差距,以确保益生菌作为抗生素替代疗法适合牲畜生产商的长期选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
In vitro antimicrobial susceptibility of clinical isolates from adult and paediatric patients in Jordan: Antimicrobial Testing Leadership and Surveillance (ATLAS) 2010–2021 Editorial: Antibiotics in engineered and natural environments: occurrence, fate, kinetic and microbial impact Increased usage of doxycycline for young children with Lyme disease Unguarded liabilities: Borrelia burgdorferi’s complex amino acid dependence exposes unique avenues of inhibition Antibiogram profiles of pathogenic and commensal bacteria in goat and sheep feces on smallholder farm
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1